Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/30/19 → 7/19/22 |
Funding
- Bavarian Nordic: $263,582.00
A Randomized, Double-Blind, Multicenter Phase III Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of a Freeze-Dried Formulation of MVA-BN® Smallpox Vaccine in Healthy, Vaccinia-Naïve Subjects
- Greenberg, Richard (PI)